BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27352857)

  • 1. Reirradiation of Pediatric Tumors Using Hypofractionated Stereotactic Radiotherapy.
    Gultekin M; Cengiz M; Sezen D; Zorlu F; Yildiz F; Yazici G; Hurmuz P; Ozyigit G; Akyol F; Gurkaynak M
    Technol Cancer Res Treat; 2017 Apr; 16(2):195-202. PubMed ID: 27352857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
    Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Outcome of Hypofractionated Stereotactic Radiotherapy With CyberKnife Robotic Radiosurgery for Perioptic Pituitary Adenoma.
    Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Swangsilpa T; Sitathanee C; Jiarpinitnun C; Vitoonpanich P; Yongvithisatid P
    Technol Cancer Res Treat; 2016 Dec; 15(6):NP10-NP15. PubMed ID: 26424501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults.
    Chandy E; Taylor H; Gaito S; Wells E; Jones C; Meehan C; Burland H; Stone J; Snowball C; Mashru J; Riddell C; Hon Y; Welsh L; Saran F; Mandeville H
    Clin Oncol (R Coll Radiol); 2020 May; 32(5):316-326. PubMed ID: 31813663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated stereotactic photon radiotherapy of posteriorly located choroidal melanoma with five fractions at ten Gy--clinical results after six years of experience.
    Dunavoelgyi R; Zehetmayer M; Gleiss A; Geitzenauer W; Kircher K; Georg D; Schmidt-Erfurth U; Poetter R; Dieckmann K
    Radiother Oncol; 2013 Aug; 108(2):342-7. PubMed ID: 24044800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas.
    Yuce Sari S; Cengiz M; Dauletkazin A; Yazici G; Gultekin M; Hurmuz P; Yildiz F; Zorlu F; Gurkaynak M; Akyol F; Ozyigit G
    Cancer Radiother; 2019 Dec; 23(8):853-859. PubMed ID: 31640927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of perioptic tumors treated with hypofractionated stereotactic radiotherapy using CyberKnife® stereotactic radiosurgery.
    Puataweepong P; Dhanachai M; Hansasuta A; Dangprasert S; Sitathanee C; Ruangkanchanasetr R; Yongvithisatid P
    J Neurooncol; 2018 Sep; 139(3):679-688. PubMed ID: 29846895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
    Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
    Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
    Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study to assess the efficacy of hypofractionated stereotactic radiotherapy in patients with large cavernous sinus hemangiomas.
    Wang X; Liu X; Mei G; Dai J; Pan L; Wang E
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e223-30. PubMed ID: 22361080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Effect of Hypofractionated Stereotactic Radiotherapy Using CyberKnife for High Volume Cavernous Sinus Cavernous Hemangiomas.
    Huang L; Sun L; Wang W; Cui Z; Zhang Z; Li J; Wang Y; Wang J; Yu X; Ling Z; Qu B; Pan LS
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819876981. PubMed ID: 31530156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation for recurrent primary central nervous system tumors: Eight-year audit from a tertiary cancer care center in South India.
    Menon D; Chelakkot PG
    Indian J Cancer; 2017; 54(2):409-414. PubMed ID: 29469068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
    Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
    AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
    Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
    BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?
    Fokas E; Wacker U; Gross MW; Henzel M; Encheva E; Engenhart-Cabillic R
    Strahlenther Onkol; 2009 Apr; 185(4):235-40. PubMed ID: 19370426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.
    Attal J; Chaltiel L; Lubrano V; Sol JC; Lanaspeze C; Vieillevigne L; Latorzeff I; Cohen-Jonathan Moyal E
    J Neurooncol; 2018 Jan; 136(2):413-419. PubMed ID: 29273890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation for Recurrent Pediatric Central Nervous System Malignancies: A Multi-institutional Review.
    Rao AD; Rashid AS; Chen Q; Villar RC; Kobyzeva D; Nilsson K; Dieckmann K; Nechesnyuk A; Ermoian R; Alcorn S; MacDonald SM; Ladra MM; Ford EC; Winey BA; Figueiredo MLS; Chen MJ; Terezakis SA
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):634-641. PubMed ID: 29280457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.